Bank Of America Corp Fsd Pharma Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.99 - $2.04 $594 - $1,224	-600 Reduced 99.83%	1 $0
Q1 2023 May 12, 2023	BUY	$0.77 - $1.81 $462 - $1,086	600 Added 60000.0%	601 $0
Q3 2022 Nov 14, 2022	SELL	$0.78 - $1.02 $234 - $306	-300 Reduced 99.67%	1 $0
Q2 2022 Aug 12, 2022	BUY	$0.78 - $1.1 $234 - $330	300 Added 30000.0%	301 $0
Q1 2022 May 16, 2022	SELL	$0.82 - $1.1 $5,248 - $7,040	-6,400 Reduced 99.98%	1 $0

Q4 2021 Feb 08, 2022	BUY	$0.96 - $1.63 $6,144 - $10,432	6,400 Added 640000.0%	6,401 $7,000
Q3 2021 Nov 15, 2021	SELL	$1.45 - $1.84 $6,380 - $8,096	-4,400 Reduced 99.98%	1 $0
Q2 2021 Sep 13, 2021	BUY	$1.56 - $2.13 $6,865 - $9,374	4,401 New	4,401 $8,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $5.73M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.